GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
203 hedge funds and large institutions have $2.4B invested in Global Blood Therapeutics, Inc. in 2022 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 78 increasing their positions, 62 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
203
Holders Change
-2
Holders Change %
-0.98%
% of All Funds
3.21%
Holding in Top 10
10
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+42.86%
% of All Funds
0.16%
New
31
Increased
78
Reduced
62
Closed
30
Calls
$13.9M
Puts
$14M
Net Calls
-$21K
Net Calls Change
-$4.27M
Top Buyers
| 1 |
O
1
OrbiMed
New York
|
$54.6M |
| 2 |
2
Point72 Asset Management
Stamford,
Connecticut
|
$31.9M |
| 3 |
3
Goldman Sachs
New York
|
$63.5M |
| 4 |
LGM
4
Logos Global Management
San Francisco,
California
|
$43.3M |
| 5 |
PA
5
Perceptive Advisors
New York
|
$135M |
